Anúncio
Anúncio

ADXN

ADXN logo

Addex Therapeutics Ltd - ADR

8.15
USD
Patrocinado
+0.35
+4.49%
09 de jan., 11:52 UTC -5
Abrir

Relatórios de Lucros ADXN

Rácio de surpresa positiva

Nenhum Dado Disponível para ADXN

%

Próximo Relatório

Data do Próximo Relatório
06 de abr. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
--

Addex Therapeutics Ltd - ADR earnings per share and revenue

On 04 de dez. de 2025, ADXN reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference. The market reacted with a -6.78% price change (close before vs. close after earnings).
Looking ahead to Q4 25, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
26 de dez. de 2025 Para Q4 25
Estimativa
-$0.49
Real
-
Surpresa
-
FAQ
For Q3 2025, Addex Therapeutics Ltd - ADR reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved down -6.78%, changed from $8.99 before the earnings release to $8.38 the day after.
The next earning report is scheduled for 06 de abr. de 2026.
Based on -- analistas, Addex Therapeutics Ltd - ADR is expected to report EPS of -- and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio